These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38206595)

  • 1. Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma: A Review and Multidisciplinary 2023 Update.
    Bischoff LA; Ganly I; Fugazzola L; Buczek E; Faquin WC; Haugen BR; McIver B; McMullen CP; Newbold K; Rocke DJ; Russell MD; Ryder M; Sadow PM; Sherman E; Shindo M; Shonka DC; Singer MC; Stack BC; Wirth LJ; Wong RJ; Randolph GW
    JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):265-272. PubMed ID: 38206595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
    Musholt PB; Musholt TJ; Morgenstern SC; Worm K; Sheu SY; Schmid KW
    World J Surg; 2008 May; 32(5):722-8. PubMed ID: 18235983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
    Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
    Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncocytic Follicular Cell-Derived Thyroid Tumors With Papillary Growth Pattern: A Clinicopathologic Study of 32 Cases.
    Suster D; Ronen N; Giorgadze T; Baisre-de Leon A; Montalvan I; Suster S
    Arch Pathol Lab Med; 2024 Sep; 148(9):997-1006. PubMed ID: 38100177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of oncocytic features in poorly differentiated thyroid carcinoma - a bi-institutional experience.
    Xu B; Lubin DJ; Dogan S; Ghossein RA; Viswanathan K
    Virchows Arch; 2023 Mar; 482(3):479-491. PubMed ID: 36346459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression Profile.
    Metovic J; Vignale C; Annaratone L; Osella-Abate S; Maletta F; Rapa I; Cabutti F; Patriarca S; Gallo M; Nikiforov YE; Volante M; Papotti M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32936917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features.
    Xu B; Reznik E; Tuttle RM; Knauf J; Fagin JA; Katabi N; Dogan S; Aleynick N; Seshan V; Middha S; Enepekides D; Casadei GP; Solaroli E; Tallini G; Ghossein R; Ganly I
    Endocrine; 2019 Apr; 64(1):97-108. PubMed ID: 30689169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome.
    Lukovic J; Petrovic I; Liu Z; Armstrong SM; Brierley JD; Tsang R; Pasternak JD; Gomez-Hernandez K; Liu A; Asa SL; Mete O
    Front Endocrinol (Lausanne); 2021; 12():795184. PubMed ID: 34975765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
    Bai S; Baloch ZW; Samulski TD; Montone KT; LiVolsi VA
    Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach.
    Jung CK; Bychkov A; Kakudo K
    Endocrinol Metab (Seoul); 2022 Oct; 37(5):703-718. PubMed ID: 36193717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma.
    Wenter V; Albert NL; Unterrainer M; Ahmaddy F; Ilhan H; Jellinek A; Knösel T; Bartenstein P; Spitzweg C; Lehner S; Todica A
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):449-460. PubMed ID: 32683470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.
    Sobrinho-Simões M; Máximo V; Castro IV; Fonseca E; Soares P; Garcia-Rostan G; Oliveira MC
    Int J Surg Pathol; 2005 Jan; 13(1):29-35. PubMed ID: 15735852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short Review: Genomic Alterations in Hürthle Cell Carcinoma.
    Ganly I; McFadden DG
    Thyroid; 2019 Apr; 29(4):471-479. PubMed ID: 30848171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma.
    Wei S; LiVolsi VA; Montone KT; Morrissette JJ; Baloch ZW
    Endocr Pathol; 2015 Dec; 26(4):365-9. PubMed ID: 26530486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Columnar Cell Thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary Thyroid Carcinoma and Follicular Neoplasms.
    Higgins KE; Sadow PM; Johnson DN; Wang P; Wanjari P; Cipriani NA
    Head Neck Pathol; 2024 May; 18(1):39. PubMed ID: 38727854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization.
    Tallini G; Hsueh A; Liu S; Garcia-Rostan G; Speicher MR; Ward DC
    Lab Invest; 1999 May; 79(5):547-55. PubMed ID: 10334566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of molecular testing on detecting mimics of oncocytic neoplasms in thyroid fine-needle aspirates diagnosed as follicular neoplasm of Hürthle cell (oncocytic) type.
    Landau MS; Nikiforov YE; Ohori NP; Chiosea SI
    Cancer Cytopathol; 2021 Oct; 129(10):788-797. PubMed ID: 33901345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management.
    Xu B; Ghossein R
    Eur J Surg Oncol; 2018 Mar; 44(3):338-347. PubMed ID: 28554832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent Hurthle cell thyroid carcinoma does not preclude long-term survival: a case report and review of the literature.
    Blossey RD; Kleine-Döpke D; Ringe KI; Pöhnert D; Ringe B; Klempnauer J; Beetz O
    J Med Case Rep; 2021 Aug; 15(1):399. PubMed ID: 34376229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
    Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
    BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.